{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:40:06Z","timestamp":1794649206791,"version":"4.9.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118344","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:52:41Z","timestamp":1754751161000},"page":"118344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Unravelling the potential of small molecule tumor necrosis factor-\u03b1 (TNF) inhibitors: A comprehensive review"],"prefix":"10.1016","volume":"130","author":[{"given":"Yaman","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagula","family":"Shankaraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Rao","family":"Kaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bmc.2025.118344_bb0005","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2025.118344_bb0010","doi-asserted-by":"crossref","unstructured":"Malerich, P, Elston, DM. Introduction to TNF\/Pathophysiology of TNF. TNF-Alpha Inhibitors. Birkh\u00e4user-Verlag; 2006:1\u20138. https:\/\/doi.org\/10.1007\/3-7643-7438-1_1.","DOI":"10.1007\/3-7643-7438-1_1"},{"issue":"3","key":"10.1016\/j.bmc.2025.118344_bb0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/157.3.413","article-title":"Cachectin: a hormone that triggers acute shock and chronic Cachexia","volume":"157","author":"Tracey","year":"1988","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0021-9258(17)43716-1","article-title":"Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization","volume":"259","author":"Aggarwal","year":"1984","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0025","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0021-9258(18)89560-6","article-title":"Human tumor necrosis factor. Production, purification, and characterization","volume":"260","author":"Aggarwal","year":"1985","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0030","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/S0021-9258(18)89559-X","article-title":"Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line","volume":"260","author":"Aggarwal","year":"1985","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.med.45.1.491","article-title":"Tumor necrosis factor: a pleiotropic cytokine and therapuetic target","volume":"45","author":"Tracey","year":"1994","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.bmc.2025.118344_bb0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(89)90143-3","article-title":"Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells","volume":"122","author":"Peck","year":"1989","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1084\/jem.185.1.81","article-title":"Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells","volume":"185","author":"Lazdins","year":"1997","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.bmc.2025.118344_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jlb.51.3.296","article-title":"Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense","volume":"51","author":"Birkland","year":"1992","journal-title":"J Leukoc Biol"},{"issue":"6618","key":"10.1016\/j.bmc.2025.118344_bb0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-\u03b1","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bmc.2025.118344_bb0065","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1073\/pnas.95.7.3408","article-title":"Crystal structure of the catalytic domain of human tumor necrosis factor-\u03b1-converting enzyme","volume":"95","author":"Maskos","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2025.118344_bb0070","series-title":"Brenner\u2019s Encyclopedia of Genetics","first-page":"229","article-title":"Tumor necrosis factor","author":"Atzeni","year":"2013"},{"key":"10.1016\/j.bmc.2025.118344_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-025-00760-8","article-title":"Global, regional, and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021","volume":"13","author":"Ma","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.bmc.2025.118344_bb0080","doi-asserted-by":"crossref","unstructured":"Ng, SC, Shi, HY, Hamidi, N, et al . Articles worldwide incidence and prevalence of inflammatory bowel disease in the 21st century : a systematic review of population-based studies. Lancet 390(10114):2769-2778. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0.","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"10.1016\/j.bmc.2025.118344_bb0085","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"issue":"September","key":"10.1016\/j.bmc.2025.118344_bb0090","article-title":"Epidemiology and risk factors in non-infectious uveitis\u202f: a systematic review","volume":"8","author":"Joltikov","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.bmc.2025.118344_bb0095","first-page":"100","article-title":"Tumor necrosis factor alpha ( TNF \u03b1 ) -binding imprinted polymers. A non-systemic therapeutic approach for inflammatory bowel diseases","volume":"8","author":"Arad","year":"2023","journal-title":"Eur J Med Chem Reports"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms, and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.bmc.2025.118344_bb0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00011-013-0633-0","article-title":"TNF-\u03b1 signalling and inflammation: interactions between old acquaintances","volume":"62","author":"Zelov\u00e1","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bmc.2025.118344_bb0110","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-dom\u00ednguez M. The role of TNF- \u03b1 in neuropathic pain : an immunotherapeutic perspective Life 2025 785.15(5):1-23 https:\/\/doi.org\/10.3390\/life15050785.","DOI":"10.3390\/life15050785"},{"issue":"5","key":"10.1016\/j.bmc.2025.118344_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12967-025-06122-0","article-title":"Exploring TNFR1: from discovery to targeted therapy development","volume":"23","author":"Li","year":"2025","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.bmc.2025.118344_bb0125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/2472555217706478","article-title":"An innovative high-throughput screening approach for discovery of small molecules that inhibit TNF receptors","volume":"22","author":"Lo","year":"2017","journal-title":"SLAS Discov"},{"issue":"July","key":"10.1016\/j.bmc.2025.118344_bb0130","first-page":"1","article-title":"Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders","volume":"14","author":"Gonzalez Caldito","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1479-8077.2007.00305.x","article-title":"Role of tumor necrosis factor-alpha in rheumatoid arthritis: a review","volume":"10","author":"Vasanthi","year":"2007","journal-title":"APLAR J Rheumatol"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00002281-200207000-00013","article-title":"Pathogenesis of bone erosions in rheumatoid arthritis","volume":"14","author":"Goldring","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1016\/j.bmc.2025.118344_bb0145","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0091270007301623","article-title":"The role of TNF\u03b1 in ulcerative colitis","volume":"47","author":"Sands","year":"2007","journal-title":"J Clin Pharmacol"},{"issue":"May","key":"10.1016\/j.bmc.2025.118344_bb0150","first-page":"4","article-title":"The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities","volume":"1","author":"Yost","year":"2009","journal-title":"F1000 Med Rep"},{"issue":"11","key":"10.1016\/j.bmc.2025.118344_bb0155","first-page":"1","article-title":"TNF-\u03b1 in uveitis: from bench to clinic","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drudis.2021.06.018","article-title":"TNF-\u03b1: the shape of small molecules to come?","volume":"27","author":"D\u00f6mling","year":"2022","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.bmc.2025.118344_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103575","article-title":"Small-molecule modulators of tumor necrosis factor signaling","volume":"28","author":"Ch\u00e9dotal","year":"2023","journal-title":"Drug Discov Today"},{"issue":"suppl 1","key":"10.1016\/j.bmc.2025.118344_bb0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0378-6323.115526","article-title":"Tumor necrosis factor-\u03b1 antagonists: side effects and their management","volume":"79","author":"Dogra","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4155\/fmc.12.192","article-title":"Small-molecule inhibitors of the interaction between TNF and TNFR","volume":"5","author":"Davis","year":"2013","journal-title":"Future Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41584-020-0388-2","article-title":"Small-molecule inhibitors get pro-inflammatory TNF into shape","volume":"16","author":"Savvides","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bmc.2025.118344_bb0185","unstructured":"Sarala Balachandran, Ram Vishwakarma, Venkata Rao Kaki, Vitthal Yadav, Siddheshwar Chauthe, Somesh Sharma, Sapna Parikh FK. Xinye YANG, Shengqiang PAN, Facheng MA, Yingxun ZHANG, Xiaojun Wang, Yingjun Zhang, Chuanfei JIN, Ji Zhang.WO2008\/142623A.2008:1\u201337."},{"key":"10.1016\/j.bmc.2025.118344_bb0190","unstructured":"Hai-Yun Xiao, T.G. Murali Dhar, Jingwu Duan, Bin Jiang AJT. Substituted Tricyclic Heterocyclic Compounds. WO201149436A1.2016:1\u201389."},{"key":"10.1016\/j.bmc.2025.118344_bb0195","unstructured":"Maria Argiriadi, Eric Breinlinger, Justin D. Dietrich, Michael Friedman, David Ihle, Michael Morytko, Kelly Mullen, Augustine Osuma, Gloria Y. Lo Schiavo NSW. Indazolones as modulators of TNF signaling.WO2016\/168633A1.2016:1\u2013326."},{"key":"10.1016\/j.bmc.2025.118344_bb0200","unstructured":"James Philip O'connell, John Robert Porter, Alastair Lawson, Boris Kroeplien, Stephen Edward Rapecki, Timothy John Norman, Graham John Warrellow, Tracy Lynn Arakaki, Alex Buntin Burgin, William Ross Pitt, Mark Daniel Calmiano, David Andreas Schubert, Dani RJW. Novel TNF alpha structure for use in therapy. US20180231562A1.2020:1\u2013100."},{"key":"10.1016\/j.bmc.2025.118344_bb0205","first-page":"1","article-title":"Tumor necrosis factor alpha small molecule inhibitor","author":"Choi","year":"2020","journal-title":"US20230000861A1"},{"key":"10.1016\/j.bmc.2025.118344_bb0210","first-page":"1","article-title":"A small molecule TNF-alpha inhibitor, and preparation method, and use thereof","author":"Sun","year":"2022","journal-title":"US20240285551A1"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0215","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0192-0561(92)90125-5","article-title":"Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor \u03b1","volume":"14","author":"Grazioli","year":"1992","journal-title":"Int J Immunopharmacol"},{"issue":"17","key":"10.1016\/j.bmc.2025.118344_bb0220","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/jm9603328","article-title":"Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity","volume":"39","author":"Muller","year":"1996","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118344_bb0225","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0006-2952(99)00150-1","article-title":"Inhibition of tumor necrosis factor-\u03b1 (TNF-\u03b1)\/TNF-\u03b1 receptor binding by structural analogues of suramin","volume":"58","author":"Mancini","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"5750","key":"10.1016\/j.bmc.2025.118344_bb0230","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.1116304","article-title":"Small-molecule inhibition of TNF-\u03b1","volume":"310","author":"He","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bmc.2025.118344_bb0235","article-title":"Metal complexes in medicine: an overview and update from a drug design perspective","volume":"14","author":"Sodhi","year":"2019","journal-title":"Cancer Ther Oncol Int J"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2025.118344_bb0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cbpa.2012.01.013","article-title":"The potential of organometallic complexes in medicinal chemistry","volume":"16","author":"Gasser","year":"2012","journal-title":"Curr Opin Chem Biol"},{"issue":"2","key":"10.1016\/j.bmc.2025.118344_bb0245","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1039\/C4SC03094J","article-title":"Metal complexes as potential modulators of inflammatory and autoimmune responses","volume":"6","author":"Leung","year":"2015","journal-title":"Chem Sci"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0250","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/ar400266c","article-title":"Organoiridium complexes: anticancer agents and catalysts","volume":"47","author":"Liu","year":"2014","journal-title":"Acc Chem Res"},{"issue":"36","key":"10.1016\/j.bmc.2025.118344_bb0255","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1002\/anie.201202937","article-title":"A metal-based inhibitor of tumor necrosis factor-\u03b1","volume":"51","author":"Leung","year":"2012","journal-title":"Angew Chem Int Ed"},{"issue":"8","key":"10.1016\/j.bmc.2025.118344_bb0260","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/acs.jmedchem.6b00112","article-title":"Identification of an iridium(III)-based inhibitor of tumor necrosis factor-\u03b1","volume":"59","author":"Kang","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118344_bb0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jorganchem.2016.02.001","article-title":"Iridium complexes inhibit tumor necrosis factor-\u03b1 by utilizing light and mixed ligands","volume":"808","author":"Sauvageot","year":"2016","journal-title":"J Organomet Chem"},{"issue":"3","key":"10.1016\/j.bmc.2025.118344_bb0270","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"10.1016\/j.bmc.2025.118344_bb0275","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.1021\/acs.jmedchem.4c02736","article-title":"Natural products driven medicinal chemistry","volume":"67","author":"Bharate","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118344_bb0280","doi-asserted-by":"crossref","unstructured":"Molinari, G. Natural products in drug discovery: present status and perspectives. In: 2009:13\u201327. https:\/\/doi.org\/10.1007\/978-1-4419-1132-2_2.","DOI":"10.1007\/978-1-4419-1132-2_2"},{"issue":"9","key":"10.1016\/j.bmc.2025.118344_bb0285","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/biomedicines9091250","article-title":"A novel competitive binding screening assay reveals Sennoside B as a potent natural product inhibitor of TNF-\u03b1","volume":"9","author":"Peng","year":"2021","journal-title":"Biomedicines"},{"issue":"16","key":"10.1016\/j.bmc.2025.118344_bb0290","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1039\/b902041a","article-title":"Saponins as novel TNF-\u03b1 inhibitors: isolation of saponins and a nor-pseudoguaianolide from Parthenium hysterophorus","volume":"7","author":"Shah","year":"2009","journal-title":"Org Biomol Chem"},{"issue":"11","key":"10.1016\/j.bmc.2025.118344_bb0295","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.bcp.2012.08.025","article-title":"Japonicone a antagonizes the activity of TNF-\u03b1 by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1","volume":"84","author":"Hu","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"19","key":"10.1016\/j.bmc.2025.118344_bb0300","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1007\/s00216-016-9633-6","article-title":"Identification of a ligand for tumor necrosis factor receptor from Chinese herbs by a combination of surface plasmon resonance biosensor and UPLC-MS","volume":"408","author":"Cao","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bmc.2025.118344_bb0305","doi-asserted-by":"crossref","unstructured":"Parves MR, Mahmud S, Riza YM, et al. Inhibition of TNF-Alpha Using Plant-Derived Small Molecules for Treatment of Inflammation-Mediated Diseases. In: The 1st International Electronic Conference on Biomolecules: Natural and Bio-Inspired Therapeutics for Human Diseases. MDPI; 2020:13. doi:https:\/\/doi.org\/10.3390\/IECBM2020-08586.","DOI":"10.3390\/IECBM2020-08586"},{"issue":"21","key":"10.1016\/j.bmc.2025.118344_bb0310","article-title":"A small molecule selected from a DNA-encoded library of natural products that binds to TNF-\u03b1 and attenuates inflammation in vivo","volume":"9","author":"Wang","year":"2022","journal-title":"Adv Sci"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0315","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1367-5931(00)00110-1","article-title":"High-throughput screening: new technology for the 21st century","volume":"4","author":"Hertzberg","year":"2000","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmc.2025.118344_bb0320","doi-asserted-by":"crossref","unstructured":"Santos CC, Lionel JR, Peres RB, et al. In Vitro, In Silico, and In Vivo Analyses of Novel Aromatic Amidines against Trypanosoma cruzi. Antimicrob Agents Chemother. 2018;62(2). doi:https:\/\/doi.org\/10.1128\/AAC.02205-17.","DOI":"10.1128\/AAC.02205-17"},{"issue":"11\u221212","key":"10.1016\/j.bmc.2025.118344_bb0325","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","article-title":"Pharmacophore modeling and applications in drug discovery: challenges and recent advances","volume":"15","author":"Yang","year":"2010","journal-title":"Drug Discov Today"},{"issue":"10","key":"10.1016\/j.bmc.2025.118344_bb0330","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1016\/j.bmcl.2011.03.032","article-title":"Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery","volume":"21","author":"Erlanson","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118344_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00315","article-title":"Advances in the development of shape similarity methods and their application in drug discovery","volume":"6","author":"Kumar","year":"2018","journal-title":"Front Chem"},{"issue":"31","key":"10.1016\/j.bmc.2025.118344_bb0340","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.0504301102","article-title":"Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107","volume":"102","author":"Murali","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.bmc.2025.118344_bb0345","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1016\/j.bmcl.2010.08.116","article-title":"Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening","volume":"20","author":"Choi","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bmc.2025.118344_bb0350","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2010.05.016","article-title":"A small oxazine compound as an anti-tumor agent: a novel pyranoside mimetic that binds to VEGF, HB-EGF, and TNF-\u03b1","volume":"297","author":"Basappa","year":"2010","journal-title":"Cancer Lett"},{"issue":"16","key":"10.1016\/j.bmc.2025.118344_bb0355","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1002\/anie.200907360","article-title":"Structure-based discovery of natural-product-like TNF-\u03b1 inhibitors","volume":"49","author":"Chan","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"10.1016\/j.bmc.2025.118344_bb0360","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cmdc.201100016","article-title":"Structure-based repurposing of FDA-approved drugs as TNF-\u03b1 inhibitors","volume":"6","author":"Leung","year":"2011","journal-title":"ChemMedChem"},{"issue":"18","key":"10.1016\/j.bmc.2025.118344_bb0365","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1074\/jbc.M113.521708","article-title":"A novel small-molecule tumor necrosis factor \u03b1 inhibitor attenuates inflammation in a hepatitis mouse model","volume":"289","author":"Ma","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118344_bb0370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejmech.2014.07.091","article-title":"Discovery of highly potent TNF\u03b1 inhibitors using virtual screen","volume":"85","author":"Shen","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"46","key":"10.1016\/j.bmc.2025.118344_bb0375","doi-asserted-by":"crossref","first-page":"31879","DOI":"10.1074\/jbc.M114.593855","article-title":"Novel synthetic Biscoumarins target tumor necrosis factor-\u03b1 in hepatocellular carcinoma in vitro and in vivo","volume":"289","author":"Keerthy","year":"2014","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bmc.2025.118344_bb0380","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1039\/C5MD00023H","article-title":"Synthesis and biological evaluation of potential small-molecule inhibitors of tumor necrosis factor","volume":"6","author":"Papaneophytou","year":"2015","journal-title":"Medchemcomm"},{"issue":"3","key":"10.1016\/j.bmc.2025.118344_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149317","article-title":"A new application of parallel synthesis strategy for discovery of amide-linked small molecules as potent Chondroprotective agents in TNF-\u03b1-stimulated chondrocytes","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005372","article-title":"Cheminformatics-aided discovery of small-molecule protein-protein interaction (PPI) dual inhibitors of tumor necrosis factor (TNF) and receptor activator of NF-\u03baB ligand (RANKL)","volume":"13","author":"Melagraki","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0395","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1038\/s41598-017-03427-z","article-title":"Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNF\u03b1 through combined in silico\/in vitro\/in vivo screening","volume":"7","author":"Mouhsine","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.bmc.2025.118344_bb0400","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/acs.jcim.6b00672","article-title":"Discovery of novel ligands for TNF-\u03b1 and TNF Receptor-1 through structure-based virtual screening and biological assay","volume":"57","author":"Chen","year":"2017","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1200-y","article-title":"Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury","volume":"15","author":"Rowe","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bmc.2025.118344_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00098","article-title":"Design, synthesis, and evaluation of dihydrobenzo[cd]indole-6-sulfonamide as TNF-\u03b1 inhibitors","volume":"6","author":"Deng","year":"2018","journal-title":"Front Chem"},{"issue":"592","key":"10.1016\/j.bmc.2025.118344_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav5637","article-title":"Noncompetitive inhibitors of TNFR1 probe conformational activation states","volume":"12","author":"Lo","year":"2019","journal-title":"Sci Signal"},{"issue":"9","key":"10.1016\/j.bmc.2025.118344_bb0420","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1080\/07391102.2018.1491423","article-title":"Novel tumor necrosis factor-\u03b1 (TNF-\u03b1) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models","volume":"37","author":"Zaka","year":"2019","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0425","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12967-019-1965-5","article-title":"Identification of novel inhibitors for TNF\u03b1, TNFR1 and TNF\u03b1-TNFR1 complex using pharmacophore-based approaches","volume":"17","author":"Saddala","year":"2019","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0430","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1038\/s41467-019-13616-1","article-title":"Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer","volume":"10","author":"O\u2019Connell","year":"2019","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.bmc.2025.118344_bb0435","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.1021\/acs.jmedchem.0c00377","article-title":"Discovery of an orally active small-molecule tumor necrosis factor-\u03b1 inhibitor","volume":"63","author":"Sun","year":"2020","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.bmc.2025.118344_bb0440","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1021\/acs.jmedchem.0c01732","article-title":"Biologic-like in vivo efficacy with small molecule inhibitors of TNF\u03b1 identified using scaffold hopping and structure-based drug design approaches","volume":"63","author":"Xiao","year":"2020","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0445","doi-asserted-by":"crossref","first-page":"20974","DOI":"10.1038\/s41598-020-77750-3","article-title":"Identification of potential TNF-\u03b1 inhibitors: from in silico to in vitro studies","volume":"10","author":"Zia","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.bmc.2025.118344_bb0450","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/pro.3829","article-title":"Conformational states of TNFR1 as a molecular switch for receptor function","volume":"29","author":"Lo","year":"2020","journal-title":"Protein Sci"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0455","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1039\/C5MD00549C","article-title":"De novo design of helical peptides to inhibit tumor necrosis factor-\u03b1 by disrupting its trimer formation","volume":"7","author":"Shen","year":"2016","journal-title":"Medchemcomm"},{"issue":"4","key":"10.1016\/j.bmc.2025.118344_bb0460","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1080\/07391102.2020.1831962","article-title":"Ligand-based pharmacophore modeling of TNF-\u03b1 to design novel inhibitors using virtual screening and molecular dynamics","volume":"40","author":"Jade","year":"2022","journal-title":"J Biomol Struct Dyn"},{"issue":"759","key":"10.1016\/j.bmc.2025.118344_bb0465","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abi8713","article-title":"An orally active, small-molecule TNF inhibitor that disrupts the homotrimerization interface improves inflammatory arthritis in mice","volume":"15","author":"Javaid","year":"2022","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0470","article-title":"Thalidomide-based inhibitor for TNF-\u03b1: designing and in Insilico evaluation. Futur","volume":"8","author":"Shivaleela","year":"2022","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.bmc.2025.118344_bb0475","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/acsbiomedchemau.2c00048","article-title":"Zafirlukast is a promising scaffold for selectively inhibiting TNFR1 signaling","volume":"3","author":"Vunnam","year":"2023","journal-title":"ACS Bio Med Chem Au"},{"issue":"12 December","key":"10.1016\/j.bmc.2025.118344_bb0480","first-page":"1","article-title":"Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of rheumatoid arthritis: virtual screening to comprehensive in silico investigation","volume":"19","author":"Nabi","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118344_bb0485","doi-asserted-by":"crossref","unstructured":"Tettevi EJ, Kuevi DNO, Sumabe BK, et al. In silico identification of a potential TNF-alpha binder using a structural similarity: a potential drug repurposing approach to the Management of Alzheimer's disease. Biomed Res Int 2024;2024. doi:https:\/\/doi.org\/10.1155\/2024\/9985719.","DOI":"10.1155\/2024\/9985719"},{"key":"10.1016\/j.bmc.2025.118344_bb0490","first-page":"1","article-title":"First-in-human single and multiple ascending dose studies of Balinatunfib, a small molecule inhibitor of TNFR1 signaling in healthy participants","author":"Nassr","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bmc.2025.118344_bb0495","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c00323","article-title":"Discovery of orally efficacious bridged piperazines as smTNF modulators","author":"Bian","year":"2025","journal-title":"J Med Chem"},{"issue":"21","key":"10.1016\/j.bmc.2025.118344_bb0500","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1073\/pnas.211178398","article-title":"Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-\u03b1","volume":"98","author":"Carter","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.bmc.2025.118344_bb0505","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.chembiol.2009.09.011","article-title":"Discovery of TNF inhibitors from a DNA-encoded chemical library based on Diels-Alder cycloaddition","volume":"16","author":"Buller","year":"2009","journal-title":"Chem Biol"},{"issue":"1","key":"10.1016\/j.bmc.2025.118344_bb0510","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/acs.jmedchem.0c01280","article-title":"Development of orally efficacious allosteric inhibitors of TNF\u03b1 via fragment-based drug design","volume":"64","author":"Dietrich","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118344_bb0515","first-page":"1","article-title":"In silico discovery of plant-origin natural product inhibitors of tumor necrosis factor ( TNF ) and receptor activator of NF-\u03ba b ligand ( RANKL )","volume":"9","author":"Melagraki","year":"2018"},{"issue":"9","key":"10.1016\/j.bmc.2025.118344_bb0520","article-title":"Targeted protein degradation\u202f: advances in drug discovery and clinical practice","volume":"308","author":"Zhong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.bmc.2025.118344_bb0525","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ibd\/izy123","article-title":"Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bmc.2025.118344_bb0530","doi-asserted-by":"crossref","unstructured":"Gupta, N, Rahaman, A, Ananda, S, Chettupalli, K, Pawar, S, Bukke, N. Nanomedicine for the management of rheumatoid arthritis\u00a0: current status and prospective therapeutic approaches. Springer Nature Singapore; 2025. https:\/\/doi.org\/10.1007\/s44337-025-00316-7.","DOI":"10.1007\/s44337-025-00316-7"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:58:41Z","timestamp":1762347521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625002858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":106,"alternative-id":["S0968089625002858"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118344","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the potential of small molecule tumor necrosis factor-\u03b1 (TNF) inhibitors: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118344"}}